Global Medical Institutes, LLC   Report issue

For profit Phase 2
Founded: Princeton NJ United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2008
NCT00758966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

fluoxetine (prozac) (1 trial)

naltrexone (revia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Compulsive Personality Disorder (Phase 2)

Disease (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2